 | • レポートコード：MRC2-11QY11330 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は子宮頸がんスクリーニングのグローバル市場について調査・分析したレポートです。種類別（パパニコロウ検査、HPV検査、酢酸目視検査）市場規模、用途別（病院、診断研究所、クリニック、地域保健センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別子宮頸がんスクリーニングの競争状況、市場シェア ・世界の子宮頸がんスクリーニング市場：種類別市場規模 2015年-2020年（パパニコロウ検査、HPV検査、酢酸目視検査） ・世界の子宮頸がんスクリーニング市場：種類別市場規模予測 2021年-2026年（パパニコロウ検査、HPV検査、酢酸目視検査） ・世界の子宮頸がんスクリーニング市場：用途別市場規模 2015年-2020年（病院、診断研究所、クリニック、地域保健センター） ・世界の子宮頸がんスクリーニング市場：用途別市場規模予測 2021年-2026年（病院、診断研究所、クリニック、地域保健センター） ・北米の子宮頸がんスクリーニング市場分析：米国、カナダ ・ヨーロッパの子宮頸がんスクリーニング市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの子宮頸がんスクリーニング市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の子宮頸がんスクリーニング市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの子宮頸がんスクリーニング市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Hologic、Qiagen、Hoffmann-La Roche、Quest Diagnostics、Becton、Dickinson、OncoHealth ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops.
Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. The market for Cervical Cancer Screening is also driven by the increase in aging female population with the increase in awareness Programs for Cervical Cancer Screening. Comprehensive approach taken by many organizations to prevent and control Cervical Cancer is also expected to fuel the market revenue for Cervical Cancer Screening over the forecast period.
Market Analysis and Insights: Global Cervical Cancer Screening Market
The global Cervical Cancer Screening market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cervical Cancer Screening Scope and Market Size
Cervical Cancer Screening market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cervical Cancer Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Hologic
Qiagen
Hoffmann-La Roche
Quest Diagnostics
Becton
Dickinson
OncoHealth
Market segment by Type, the product can be split into
Pap Tests
HPV Test
Visual Inspection Using Acetic Acid
Market segment by Application, split into
Hospitals
Diagnostic Laboratories
Clinics
Community Health Center
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cervical Cancer Screening Revenue
1.4 Market by Type
1.4.1 Global Cervical Cancer Screening Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pap Tests
1.4.3 HPV Test
1.4.4 Visual Inspection Using Acetic Acid
1.5 Market by Application
1.5.1 Global Cervical Cancer Screening Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Laboratories
1.5.4 Clinics
1.5.5 Community Health Center
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cervical Cancer Screening Market Perspective (2015-2026)
2.2 Global Cervical Cancer Screening Growth Trends by Regions
2.2.1 Cervical Cancer Screening Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cervical Cancer Screening Historic Market Share by Regions (2015-2020)
2.2.3 Cervical Cancer Screening Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cervical Cancer Screening Market Growth Strategy
2.3.6 Primary Interviews with Key Cervical Cancer Screening Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cervical Cancer Screening Players by Market Size
3.1.1 Global Top Cervical Cancer Screening Players by Revenue (2015-2020)
3.1.2 Global Cervical Cancer Screening Revenue Market Share by Players (2015-2020)
3.1.3 Global Cervical Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cervical Cancer Screening Market Concentration Ratio
3.2.1 Global Cervical Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cervical Cancer Screening Revenue in 2019
3.3 Cervical Cancer Screening Key Players Head office and Area Served
3.4 Key Players Cervical Cancer Screening Product Solution and Service
3.5 Date of Enter into Cervical Cancer Screening Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cervical Cancer Screening Historic Market Size by Type (2015-2020)
4.2 Global Cervical Cancer Screening Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cervical Cancer Screening Market Size by Application (2015-2020)
5.2 Global Cervical Cancer Screening Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cervical Cancer Screening Market Size (2015-2020)
6.2 Cervical Cancer Screening Key Players in North America (2019-2020)
6.3 North America Cervical Cancer Screening Market Size by Type (2015-2020)
6.4 North America Cervical Cancer Screening Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cervical Cancer Screening Market Size (2015-2020)
7.2 Cervical Cancer Screening Key Players in Europe (2019-2020)
7.3 Europe Cervical Cancer Screening Market Size by Type (2015-2020)
7.4 Europe Cervical Cancer Screening Market Size by Application (2015-2020)
8 China
8.1 China Cervical Cancer Screening Market Size (2015-2020)
8.2 Cervical Cancer Screening Key Players in China (2019-2020)
8.3 China Cervical Cancer Screening Market Size by Type (2015-2020)
8.4 China Cervical Cancer Screening Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cervical Cancer Screening Market Size (2015-2020)
9.2 Cervical Cancer Screening Key Players in Japan (2019-2020)
9.3 Japan Cervical Cancer Screening Market Size by Type (2015-2020)
9.4 Japan Cervical Cancer Screening Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cervical Cancer Screening Market Size (2015-2020)
10.2 Cervical Cancer Screening Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cervical Cancer Screening Market Size by Type (2015-2020)
10.4 Southeast Asia Cervical Cancer Screening Market Size by Application (2015-2020)
11 India
11.1 India Cervical Cancer Screening Market Size (2015-2020)
11.2 Cervical Cancer Screening Key Players in India (2019-2020)
11.3 India Cervical Cancer Screening Market Size by Type (2015-2020)
11.4 India Cervical Cancer Screening Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cervical Cancer Screening Market Size (2015-2020)
12.2 Cervical Cancer Screening Key Players in Central & South America (2019-2020)
12.3 Central & South America Cervical Cancer Screening Market Size by Type (2015-2020)
12.4 Central & South America Cervical Cancer Screening Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Cervical Cancer Screening Introduction
13.1.4 Abbott Laboratories Revenue in Cervical Cancer Screening Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Hologic
13.2.1 Hologic Company Details
13.2.2 Hologic Business Overview
13.2.3 Hologic Cervical Cancer Screening Introduction
13.2.4 Hologic Revenue in Cervical Cancer Screening Business (2015-2020)
13.2.5 Hologic Recent Development
13.3 Qiagen
13.3.1 Qiagen Company Details
13.3.2 Qiagen Business Overview
13.3.3 Qiagen Cervical Cancer Screening Introduction
13.3.4 Qiagen Revenue in Cervical Cancer Screening Business (2015-2020)
13.3.5 Qiagen Recent Development
13.4 Hoffmann-La Roche
13.4.1 Hoffmann-La Roche Company Details
13.4.2 Hoffmann-La Roche Business Overview
13.4.3 Hoffmann-La Roche Cervical Cancer Screening Introduction
13.4.4 Hoffmann-La Roche Revenue in Cervical Cancer Screening Business (2015-2020)
13.4.5 Hoffmann-La Roche Recent Development
13.5 Quest Diagnostics
13.5.1 Quest Diagnostics Company Details
13.5.2 Quest Diagnostics Business Overview
13.5.3 Quest Diagnostics Cervical Cancer Screening Introduction
13.5.4 Quest Diagnostics Revenue in Cervical Cancer Screening Business (2015-2020)
13.5.5 Quest Diagnostics Recent Development
13.6 Becton
13.6.1 Becton Company Details
13.6.2 Becton Business Overview
13.6.3 Becton Cervical Cancer Screening Introduction
13.6.4 Becton Revenue in Cervical Cancer Screening Business (2015-2020)
13.6.5 Becton Recent Development
13.7 Dickinson
13.7.1 Dickinson Company Details
13.7.2 Dickinson Business Overview
13.7.3 Dickinson Cervical Cancer Screening Introduction
13.7.4 Dickinson Revenue in Cervical Cancer Screening Business (2015-2020)
13.7.5 Dickinson Recent Development
13.8 OncoHealth
13.8.1 OncoHealth Company Details
13.8.2 OncoHealth Business Overview
13.8.3 OncoHealth Cervical Cancer Screening Introduction
13.8.4 OncoHealth Revenue in Cervical Cancer Screening Business (2015-2020)
13.8.5 OncoHealth Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cervical Cancer Screening Key Market Segments
Table 2. Key Players Covered: Ranking by Cervical Cancer Screening Revenue
Table 3. Ranking of Global Top Cervical Cancer Screening Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cervical Cancer Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pap Tests
Table 6. Key Players of HPV Test
Table 7. Key Players of Visual Inspection Using Acetic Acid
Table 8. Global Cervical Cancer Screening Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cervical Cancer Screening Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cervical Cancer Screening Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cervical Cancer Screening Market Share by Regions (2015-2020)
Table 12. Global Cervical Cancer Screening Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cervical Cancer Screening Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cervical Cancer Screening Market Growth Strategy
Table 18. Main Points Interviewed from Key Cervical Cancer Screening Players
Table 19. Global Cervical Cancer Screening Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cervical Cancer Screening Market Share by Players (2015-2020)
Table 21. Global Top Cervical Cancer Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Cancer Screening as of 2019)
Table 22. Global Cervical Cancer Screening by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cervical Cancer Screening Product Solution and Service
Table 25. Date of Enter into Cervical Cancer Screening Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cervical Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cervical Cancer Screening Market Size Share by Type (2015-2020)
Table 29. Global Cervical Cancer Screening Revenue Market Share by Type (2021-2026)
Table 30. Global Cervical Cancer Screening Market Size Share by Application (2015-2020)
Table 31. Global Cervical Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cervical Cancer Screening Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cervical Cancer Screening Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cervical Cancer Screening Market Share (2019-2020)
Table 35. North America Cervical Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cervical Cancer Screening Market Share by Type (2015-2020)
Table 37. North America Cervical Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cervical Cancer Screening Market Share by Application (2015-2020)
Table 39. Europe Key Players Cervical Cancer Screening Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cervical Cancer Screening Market Share (2019-2020)
Table 41. Europe Cervical Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cervical Cancer Screening Market Share by Type (2015-2020)
Table 43. Europe Cervical Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cervical Cancer Screening Market Share by Application (2015-2020)
Table 45. China Key Players Cervical Cancer Screening Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cervical Cancer Screening Market Share (2019-2020)
Table 47. China Cervical Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 48. China Cervical Cancer Screening Market Share by Type (2015-2020)
Table 49. China Cervical Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 50. China Cervical Cancer Screening Market Share by Application (2015-2020)
Table 51. Japan Key Players Cervical Cancer Screening Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cervical Cancer Screening Market Share (2019-2020)
Table 53. Japan Cervical Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cervical Cancer Screening Market Share by Type (2015-2020)
Table 55. Japan Cervical Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cervical Cancer Screening Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cervical Cancer Screening Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cervical Cancer Screening Market Share (2019-2020)
Table 59. Southeast Asia Cervical Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cervical Cancer Screening Market Share by Type (2015-2020)
Table 61. Southeast Asia Cervical Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cervical Cancer Screening Market Share by Application (2015-2020)
Table 63. India Key Players Cervical Cancer Screening Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cervical Cancer Screening Market Share (2019-2020)
Table 65. India Cervical Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 66. India Cervical Cancer Screening Market Share by Type (2015-2020)
Table 67. India Cervical Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 68. India Cervical Cancer Screening Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cervical Cancer Screening Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cervical Cancer Screening Market Share (2019-2020)
Table 71. Central & South America Cervical Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cervical Cancer Screening Market Share by Type (2015-2020)
Table 73. Central & South America Cervical Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cervical Cancer Screening Market Share by Application (2015-2020)
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Product
Table 78. Abbott Laboratories Revenue in Cervical Cancer Screening Business (2015-2020) (Million US$)
Table 79. Abbott Laboratories Recent Development
Table 80. Hologic Company Details
Table 81. Hologic Business Overview
Table 82. Hologic Product
Table 83. Hologic Revenue in Cervical Cancer Screening Business (2015-2020) (Million US$)
Table 84. Hologic Recent Development
Table 85. Qiagen Company Details
Table 86. Qiagen Business Overview
Table 87. Qiagen Product
Table 88. Qiagen Revenue in Cervical Cancer Screening Business (2015-2020) (Million US$)
Table 89. Qiagen Recent Development
Table 90. Hoffmann-La Roche Company Details
Table 91. Hoffmann-La Roche Business Overview
Table 92. Hoffmann-La Roche Product
Table 93. Hoffmann-La Roche Revenue in Cervical Cancer Screening Business (2015-2020) (Million US$)
Table 94. Hoffmann-La Roche Recent Development
Table 95. Quest Diagnostics Company Details
Table 96. Quest Diagnostics Business Overview
Table 97. Quest Diagnostics Product
Table 98. Quest Diagnostics Revenue in Cervical Cancer Screening Business (2015-2020) (Million US$)
Table 99. Quest Diagnostics Recent Development
Table 100. Becton Company Details
Table 101. Becton Business Overview
Table 102. Becton Product
Table 103. Becton Revenue in Cervical Cancer Screening Business (2015-2020) (Million US$)
Table 104. Becton Recent Development
Table 105. Dickinson Company Details
Table 106. Dickinson Business Overview
Table 107. Dickinson Product
Table 108. Dickinson Revenue in Cervical Cancer Screening Business (2015-2020) (Million US$)
Table 109. Dickinson Recent Development
Table 110. OncoHealth Business Overview
Table 111. OncoHealth Product
Table 112. OncoHealth Company Details
Table 113. OncoHealth Revenue in Cervical Cancer Screening Business (2015-2020) (Million US$)
Table 114. OncoHealth Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cervical Cancer Screening Market Share by Type: 2020 VS 2026
Figure 2. Pap Tests Features
Figure 3. HPV Test Features
Figure 4. Visual Inspection Using Acetic Acid Features
Figure 5. Global Cervical Cancer Screening Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Clinics Case Studies
Figure 9. Community Health Center Case Studies
Figure 10. Cervical Cancer Screening Report Years Considered
Figure 11. Global Cervical Cancer Screening Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cervical Cancer Screening Market Share by Regions: 2020 VS 2026
Figure 13. Global Cervical Cancer Screening Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cervical Cancer Screening Market Share by Players in 2019
Figure 16. Global Top Cervical Cancer Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Cancer Screening as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cervical Cancer Screening Revenue in 2019
Figure 18. North America Cervical Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cervical Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cervical Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cervical Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cervical Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cervical Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cervical Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
子宮頸がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Diagnostic Test Market The global Cervical Cancer Diagnostic Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 乳癌スクリーニング検査の世界市場（～2026年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…
- 子宮頸がん治療法・診断の世界市場（～2026年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…
- 前立腺がんスクリーニングの世界市場（～2026年） Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measu…
- がん検診/スクリーニングの世界市場（～2026年） Screening means checking your body for cancer before you have symptoms. In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer. Market Analysis and Insights: Global Cancer Testing/Screening Market The global Cancer Testing/Screening market…